Literature DB >> 11883932

Osmotic resistance of high-density erythrocytes in transglutaminase 2-deficient mice.

Francesca Bernassola1, Giovanna Boumis, Marco Corazzari, Giuseppe Bertini, Gennaro Citro, Richard A Knight, Gino Amiconi, Gerry Melino.   

Abstract

Transglutaminase 2 (TGase 2) is a Ca(2+)-dependent enzyme responsible for the posttransttranslational modification of proteins by transamidation of specific polypeptide-bound glutamine residues. Elevating the intracellular concentration of Ca(2+)-ions in human erythrocytes leads to the formation of cytoskeletal and cytoplasmic protein polymers. The Ca(2+)-dependent TGase 2-dependent cross-linking activity has been proposed for its involvement in erythrocyte aging, by inducing irreversible modification of their cell shape and deformability. Accordingly, we found that high-density ("old") TGase 2(minus sign/minus sign) red blood cells (RBCs) were more resistant to osmotic stress-induced hemolysis than those from wild type mice. In addition, elevating the intracellular concentration of Ca(2+) by treatment of total RBCs with ionophore A23187 resulted in enhanced resistance of TGase 2-deficient erythrocytes compared to their normal counterpart. These findings indicate that TGase 2 may have a role in regulating structural flexibility of RBCs, possibly affecting their life span in physiopathological conditions, such as erythrocyte senescence, which are accompanied by increases in intracellular Ca(2+) concentration. (C)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11883932     DOI: 10.1006/bbrc.2002.6558

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Transglutaminase 5 is regulated by guanine-adenine nucleotides.

Authors:  Eleonora Candi; Andrea Paradisi; Alessandro Terrinoni; Valentina Pietroni; Sergio Oddi; Bruno Cadot; Vishwanath Jogini; Muthuraman Meiyappan; Jon Clardy; Alessandro Finazzi-Agro; Gerry Melino
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.